Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient be... Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations. Show more
Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024 Annual Meeting and Expo PR Newswire VICTORIA, BC, July 8, 2024 VICTORIA, BC, July 8, 2024 /PRNewswire/ - Eupraxia...
Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Exploring the Rapid Rise of Osteoarthritis" on July 9, 2024 PR Newswire VICTORIA, BC, July 3...
Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders Canada NewsWire VICTORIA, BC, June 6, 2024 VICTORIA, BC, June 6, 2024 /CNW/ - Eupraxia...
Eupraxia Pharmaceuticals to Present Data from the Phase 2 SPRINGBOARD Study in Osteoarthritis of the Knee at EULAR European Congress of Rheumatology 2024 Canada NewsWire VICTORIA, BC, June 5...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.065 | -2.44360902256 | 2.66 | 2.84 | 2.46 | 3276 | 2.58481199 | CS |
4 | -0.135 | -4.94505494505 | 2.73 | 2.87 | 2.402 | 6413 | 2.59120273 | CS |
12 | -0.195 | -6.98924731183 | 2.79 | 3.19 | 2.402 | 17541 | 2.83077683 | CS |
26 | -0.955 | -26.9014084507 | 3.55 | 3.55 | 2.402 | 20760 | 2.8351299 | CS |
52 | -0.955 | -26.9014084507 | 3.55 | 3.55 | 2.402 | 20760 | 2.8351299 | CS |
156 | -0.955 | -26.9014084507 | 3.55 | 3.55 | 2.402 | 20760 | 2.8351299 | CS |
260 | -0.955 | -26.9014084507 | 3.55 | 3.55 | 2.402 | 20760 | 2.8351299 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.